Treatment of Mild Hypomagnesemia

Oral Magnesium Therapy

• The American Gastroenterological Association recommends oral magnesium oxide at a dose of 12-24 mmol daily for the treatment of mild hypomagnesemia, with 12 mmol typically given at night 1, 2, 3, 4
• Magnesium oxide is the preferred oral supplement as it contains more elemental magnesium than other salts and is converted to magnesium chloride in the stomach 1, 3
• The initial dose of magnesium oxide is 12 mmol given at night, with a total daily dose ranging from 12-24 mmol depending on severity and response 1, 3, 4
• Administering magnesium oxide at night when intestinal transit is slowest can help maximize absorption 1, 3

Treatment Algorithm

• The first step in treating mild hypomagnesemia is to correct water and sodium depletion if present to address secondary hyperaldosteronism, which can worsen magnesium deficiency 1, 3, 5
• The second step is to initiate oral magnesium supplementation with magnesium oxide 12 mmol at night, increasing to 24 mmol daily if needed 1, 4
• If oral therapy fails, consider oral 1-alpha hydroxy-cholecalciferol in gradually increasing doses to improve magnesium balance, while monitoring serum calcium regularly to avoid hypercalcemia 1, 3

Parenteral Magnesium Options

• For patients who fail oral therapy or have severe deficiency, IV magnesium sulfate or magnesium sulfate added to saline infusion bags can be used 1, 3, 4
• Subcutaneous administration with saline is an option for patients requiring supplementation 1-3 times weekly 1, 3

Important Considerations and Pitfalls

• Most magnesium salts are poorly absorbed and may worsen diarrhea or stomal output in patients with gastrointestinal disorders 1, 3, 4
• Reducing or avoiding excess dietary lipids can help improve magnesium absorption 1, 3

Special Situations

• For patients with short bowel syndrome or malabsorption, higher doses of oral magnesium or parenteral supplementation may be required 1, 3, 5
• In cardiac arrhythmias associated with hypomagnesemia, IV magnesium 1-2 g bolus is recommended regardless of measured serum levels 6, 7, 8

Treatment of Hypomagnesemia

Monitoring and Dose Adjustment

• The target serum magnesium level should be within the normal range (1.8-2.2 mEq/L), and patients should be monitored for signs of magnesium toxicity including hypotension, drowsiness, and muscle weakness, as recommended by the American Heart Association, based on evidence from Circulation 9

When to Consider Parenteral Therapy

• Parenteral magnesium (1-2 g IV magnesium sulfate) should be reserved for symptomatic patients with severe hypomagnesemia (<1.2 mEq/L), and IV magnesium is also indicated for patients with cardiac arrhythmias associated with hypomagnesemia regardless of measured serum levels, according to guidelines based on evidence from Circulation 9

Magnesium Supplementation for Hypomagnesemia

Treatment Recommendations

• Organic magnesium salts (aspartate, citrate, lactate) have higher bioavailability than magnesium oxide or hydroxide and can be considered as alternatives 10
• A reasonable target level for plasma magnesium is >0.6 mmol/L 10

Treatment of Hypomagnesemia

Initial Assessment and Treatment Algorithm

• Organic magnesium salts (such as aspartate, citrate, lactate) have higher bioavailability than magnesium oxide or hydroxide and can be considered as alternatives for patients with hypomagnesemia 11
• For patients with malabsorption or short bowel syndrome, spreading salt and electrolyte supplements throughout the day as much as possible is recommended 11

Special Considerations

• For cardiac arrhythmias associated with hypomagnesemia, the Kidney International recommends IV magnesium 1-2 g bolus regardless of measured serum levels, and for torsades de pointes-type ventricular tachycardia with prolonged QT interval, administer 1-2 g of magnesium as an intravenous bolus over 5 minutes 11

Monitoring and Target Levels

• A reasonable minimum target serum magnesium level is >0.6 mmol/L, as suggested by the Kidney International 11

Magnesium Repletion in Patients with Magnesium Deficiency

Oral Magnesium Supplementation

• Dividing supplementation into multiple doses throughout the day is recommended for continuous repletion 12
• Organic magnesium salts (aspartate, citrate, lactate) have higher bioavailability than magnesium oxide or hydroxide and can be considered as alternatives 12

Treatment Algorithm

• A reasonable minimum target level is >0.6 mmol/L 12

Magnesium Oxide Dosing for Hypomagnesemia in Special Clinical Scenarios

Treatment of Hypomagnesemia in Patients with Short Bowel Syndrome

• For patients with short bowel syndrome or high-output jejunostomy, initially use IV magnesium sulfate, then transition to oral magnesium oxide and/or 1-alpha cholecalciferol, as recommended by the European Society of Gastroenterology 13